Sharing is caring: a call for a new era of rare disease research and development

Abstract Scientific advances in the understanding of the genetics and mechanisms of many rare diseases with previously unknown etiologies are inspiring optimism in the patient, clinical, and research communities and there is hope that disease-specific treatments are on the way. However, the rare disease community has reached a critical point in which its increasingly fragmented structure and operating models are threatening its ability to harness the full potential of advancing genomic and computational technologies. Changes are therefore needed to overcome these issues plaguing many rare diseases while also supporting economically viable therapy development. In “Data silos are undermining drug development and failing rare disease patients (Orphanet Journal of Rare Disease, Apr 2021),” we outlined many of the broad issues underpinning the increasingly fragmented and siloed nature of the rare disease space, as well as how the issues encountered by this community are representative of biomedical research more generally. Here, we propose several initiatives for key stakeholders - including regulators, private and public foundations, and research institutions - to reorient the rare disease ecosystem and its incentives in a way that we believe would cultivate and accelerate innovation. Specifically, we propose supporting non-proprietary patient registries, greater data standardization, global regulatory harmonization, and new business models that encourage data sharing and research collaboration as the default mode. Leadership needs to be integrated across sectors to drive meaningful change between patients, industry, sponsors, and academic medical centers. To transform the research and development landscape and unlock its vast healthcare, economic, and scientific potential for rare disease patients, a new model is ultimately the goal for all..

Medienart:	E-Artikel

Erscheinungsjahr:	2022
Erschienen:	2022

Enthalten in:	Zur Gesamtaufnahme - volume:17
Enthalten in:	Orphanet journal of rare diseases - 17(2022), 1 vom: 27. Okt.

Sprache:	Englisch

Beteiligte Personen:	Denton, Nathan [VerfasserIn] Mulberg, Andrew E. [VerfasserIn] Molloy, Monique [VerfasserIn] Charleston, Samantha [VerfasserIn] Fajgenbaum, David C. [VerfasserIn] Marsh, Eric D. [VerfasserIn] Howard, Paul [VerfasserIn]

Links:	Volltext [kostenfrei]

Themen:	Clinical trials Data management Drug development Knowledge bases Rare diseases Registries Research design

Anmerkungen:	© The Author(s) 2022. corrected publication 2023

doi:	10.1186/s13023-022-02529-w

funding:
Förderinstitution / Projekttitel:

PPN (Katalog-ID):	SPR051090961